{"id":"https://openalex.org/W4362548074","doi":"https://doi.org/10.1158/1535-7163.22506961.v1","title":"Supplementary Figure S4 from Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3\u2013Knockin Mice","display_name":"Supplementary Figure S4 from Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3\u2013Knockin Mice","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362548074","doi":"https://doi.org/10.1158/1535-7163.22506961.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22506961.v1","doi":"https://doi.org/10.1158/1535-7163.22506961.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506961.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22506961.v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103068048","display_name":"Elena Burova","orcid":"https://orcid.org/0000-0002-5843-4093","observed_orcids":["https://orcid.org/0000-0002-5843-4093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elena Burova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031901742","display_name":"Aynur Hermann","orcid":"https://orcid.org/0000-0002-5426-7777","observed_orcids":["https://orcid.org/0000-0002-5426-7777"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aynur Hermann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113785275","display_name":"Jie Dai","orcid":"https://orcid.org/0000-0003-3478-2170","observed_orcids":["https://orcid.org/0000-0003-3478-2170","https://orcid.org/0009-0006-6497-0841"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jie Dai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058559625","display_name":"Erica Ullman","orcid":"https://orcid.org/0000-0001-6996-9053","observed_orcids":["https://orcid.org/0000-0001-6996-9053"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erica Ullman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080367431","display_name":"G\u00e1bor Hal\u00e1sz","orcid":"https://orcid.org/0000-0002-3332-033X","observed_orcids":["https://orcid.org/0000-0002-3332-033X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabor Halasz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3332-033X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004345979","display_name":"Terra B. Potocky","orcid":"https://orcid.org/0000-0002-6981-9597","observed_orcids":["https://orcid.org/0000-0002-6981-9597"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Terra Potocky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033090011","display_name":"Seongwon Hong","orcid":"https://orcid.org/0000-0002-0626-5558","observed_orcids":["https://orcid.org/0000-0002-0626-5558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seongwon Hong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079273822","display_name":"Matt Liu","orcid":"https://orcid.org/0000-0002-8586-7337","observed_orcids":["https://orcid.org/0000-0002-8586-7337"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002553975","display_name":"Omaira Allbritton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Omaira Allbritton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031417376","display_name":"Amy Woodruff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy Woodruff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074061529","display_name":"Jerry Pei","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerry Pei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003106049","display_name":"Ashique Rafique","orcid":"https://orcid.org/0000-0003-4078-7242","observed_orcids":["https://orcid.org/0000-0003-4078-7242"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashique Rafique","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079368099","display_name":"William T. Poueymirou","orcid":"https://orcid.org/0000-0003-3164-7248","observed_orcids":["https://orcid.org/0000-0003-3164-7248"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William Poueymirou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086781096","display_name":"Joel W. Martin","orcid":"https://orcid.org/0000-0001-5607-3338","observed_orcids":["https://orcid.org/0000-0001-5607-3338"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joel Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111467970","display_name":"Douglas MacDonald","orcid":"https://orcid.org/0000-0002-3369-8754","observed_orcids":["https://orcid.org/0000-0002-3369-8754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douglas MacDonald","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017367178","display_name":"William C. Olson","orcid":"https://orcid.org/0000-0001-6254-0641","observed_orcids":["https://orcid.org/0000-0001-6254-0641"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William C. Olson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101917021","display_name":"Andrew J. Murphy","orcid":"https://orcid.org/0000-0003-4152-4081","observed_orcids":["https://orcid.org/0000-0003-4152-4081"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Murphy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059111563","display_name":"Ella Ioffe","orcid":"https://orcid.org/0000-0001-6117-2824","observed_orcids":["https://orcid.org/0000-0001-6117-2824"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ella Ioffe","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6117-2824","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015053419","display_name":"Gavin Thurston","orcid":"https://orcid.org/0000-0002-4105-5919","observed_orcids":["https://orcid.org/0000-0002-4105-5919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gavin Thurston","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014170286","display_name":"Markus Mohrs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Markus Mohrs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.8730000257492065},{"id":"https://openalex.org/keywords/anti-lag-3-antibody","display_name":"anti-LAG-3 antibody","score":0.9580000042915344},{"id":"https://openalex.org/keywords/cemiplimab","display_name":"cemiplimab","score":0.9229999780654907},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.8109999895095825},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6880000233650208},{"id":"https://openalex.org/keywords/preclinical-drug-development","display_name":"preclinical drug development","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4711441099643707},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3322443962097168},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.32435452938079834},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23069509863853455},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14010387659072876}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22506961.v1","doi":"https://doi.org/10.1158/1535-7163.22506961.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506961.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22506961","doi":"https://doi.org/10.1158/1535-7163.22506961","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506961","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22506961","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S4_from_Preclinical_Development_of_the_Anti-LAG-3_Antibody_REGN3767_Characterization_and_Activity_in_Combination_with_the_Anti-PD-1_Antibody_Cemiplimab_in_Human_i_PD-1xLAG-3_i_Knockin_Mice/22506961","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22506961.v1","doi":"https://doi.org/10.1158/1535-7163.22506961.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22506961.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2966923691","https://openalex.org/W4362493149","https://openalex.org/W2890343403","https://openalex.org/W2914274696","https://openalex.org/W2947934006","https://openalex.org/W2482411008","https://openalex.org/W4282974323","https://openalex.org/W2790928049","https://openalex.org/W2562477083","https://openalex.org/W4282975989"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"S4":[2],"shows":[3],"activity":[4],"of":[5],"REGN3767":[6],"in":[7],"an":[8],"engineered":[9],"assay":[10]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-06T00:00:00"}